Key Takeaways
Powered by lumidawealth.com
- President Trump is attacking ACA insurers as profiteers and backing Republican plans to redirect subsidies from insurers to consumers.
- In reality, many Affordable Care Act (ACA) exchange plans are losing money in 2025 as sicker, costlier enrollees—often coming off Medicaid—drive up medical expenses.
- Biden-era enhanced subsidies are set to expire next year, threatening large premium hikes in 2026, coverage losses for millions, and further pressure on pure-play ACA insurers.
- Large diversified insurers are retrenching from ACA exchanges, while remaining carriers are hiking premiums to stabilize margins, implying higher costs and less coverage for consumers over time.
What Happened?
President Trump and Republican allies have cast Obamacare as a windfall for “big, fat, rich insurance companies,” arguing that healthcare subsidies should go directly to patients instead of insurers. On the ground, the ACA individual market is far from a gravy train. Profitability has deteriorated sharply in 2025 as sicker enrollees—many transitioning from Medicaid—have pushed medical costs higher, making ACA exchanges the weakest business line for many managed-care companies.
Centene and Molina, two major ACA players, have seen their shares fall 40%–50% this year, and broader diversified players such as CVS Health’s Aetna have again decided to exit the exchanges for 2026 after prior losses. At the same time, Biden-era enhanced ACA subsidies are scheduled to lapse next year, while Republicans are promoting ideas like converting those subsidies into health savings account (HSA) contributions, adding another layer of policy uncertainty for insurers and enrollees.
Why It Matters?
For investors, the gap between political rhetoric and economic reality is material. ACA exchange business serves a lower-income, high-churn population, is heavily regulated, and is subject to a risk-adjustment program that limits upside by transferring profits from healthier to sicker plans. Price competition is intense because plans are displayed side by side and members switch carriers for small premium differences, making scale and stable risk pools hard to achieve.
With medical costs rising and the enrollee base getting sicker and smaller, insurers are posting losses and pushing through large premium hikes for 2026 to restore viability. The possible redirection of enhanced subsidies into HSAs—while ideologically attractive to conservatives—would likely do little to address high premiums for sicker, lower-income patients and could further fragment risk pools if healthier consumers gravitate to cheaper, high-deductible or catastrophic options. Politically driven uncertainty over whether enhanced tax credits are extended, redesigned, or allowed to lapse complicates actuarial planning and keeps valuations of ACA-focused insurers under pressure.
What’s Next?
Absent a bipartisan deal to extend enhanced subsidies, premiums on ACA exchanges are set to jump in 2026, pushing many enrollees either into skinnier “bronze” plans or out of coverage entirely as exchange and Medicaid enrollment drifts back toward pre-2021 levels. Over time, higher premiums should allow remaining carriers to stabilize margins, but the ACA individual market will likely remain a small, volatile, and politically exposed segment compared with employer and Medicare Advantage business.
For pure-play exchange insurers such as Oscar Health, headline risk around subsidies, Republican redesign proposals, and enrollment attrition will remain key drivers of sentiment and multiples. For diversified insurers, the rational response is continued retrenchment or very selective participation in markets where they can price adequately. At a system level, the most probable outcome is not an insurer windfall but a leaner, less generous ACA market with higher uninsured rates—underlining that while political attacks may resonate with voters, they don’t change the structural fragility of this part of the healthcare system.
